Publications Database

Tolbert L. et al. (1993)

Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium.

Journal of Autism and Developmental Disorders

23(1), pp. 193-199

Read Abstract (New Window)

Tommey J. (2003)

The guts- the problem: the first step in combating autism is to get the gut fuctioning properly.

Autism File

12 pp. 31-33

Tordjman S. et al. (2013)

Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives.

International Journal Molecular Sciences

14(10), pp. 20508-20542.

Read Abstract (New Window) Read Full (New Window)

Tsai H. et al. (2012)

Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review.

International Journal of Clinical Practice

November, 66(11), pp. 1056–1078.

Read Abstract (New Window)

Tsalamanios E. , Yanni A. E. , Koutsari C. (2006)

Omega-3 fatty acids: Role in the prevention and treatment of psychiatric disorder.

Current Psychiatry Reports

2(2), pp. 215-234

Read Abstract (New Window)

Tsilioni I. et al. (2015)

Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6.

Translational Psychiatry

5 e647.

Read Abstract (New Window) Read Full (New Window)

Cancer Research UK (2007)

What is cellular zeolite?

London: Cancer Research UK

Read Full (New Window)

University of Maryland Medical Center (2011)

Alpha-lipoic acid

Baltimore, MD: University of Maryland Medical Center

Read Full (New Window)

University of Maryland Medical Center (2010)

Immune globulin (Injection).

Baltimore, MD: University of Maryland Medical Center

Read Full (New Window)

University of Maryland Medical Center (2010)

Oxytocin.

Baltimore, MD: University of Maryland Medical Center

Read Full (New Window)

Voigt R. G. et al. (2014)

A randomized, double-blind, placebo-controlled trial of dietary docosahexaenoic acid (DHA) supplementation in children with autism.

Journal of Pediatric Gastroenterology and Nutrition

June, 58(6), pp. 715-722.

Read Abstract (New Window)

Vyas A. K. , White N. H. (2011)

Case of hypercalcemia secondary to hypervitaminosis a in a 6-year-old boy with autism.

Case Reports in Endocrinology

Read Abstract (New Window) Read Full (New Window)

Wake R. et al. (2013)

Yokukansan (TJ-54) for irritability associated with pervasive developmental disorder in children and adolescents: a 12-week prospective, open-label study.

Journal of Child and Adolescent Psychopharmacology

23(5), pp. 329-336.

Read Abstract (New Window)

Watanabe T. et al. (2015)

Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.

Brain

November, 138(11), pp. 3400-3412.

Read Abstract (New Window)

Watanabe T. et al. (2014)

Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: A randomized trial.

Journal of the American Medical Association

February, 71(2), pp. 166-175.

Read Abstract (New Window)

Weber W. , Newmark S. (2007)

Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism.

Pediatric Clinics of North America

54(6), pp. 983-1006

Read Abstract (New Window)

WebMD (2011)

Dimethylglycine.

New York, NY: Web MD

Read Full (New Window)

Welch M. G. (2011)

Review: secretin is not effective for the treatment of children with autism spectrum disorders.

Evidence Based Mental Health

14(104),

Read Abstract (New Window)

Wender E. (1986)

The food additive-free diet in the treatment of behavior disorders: a review.

Journal of Developmental and Behavioral Pediatrics

February, 7(1), pp. 35-42.

Read Abstract (New Window)

Whitehouse A. J. (2013)

Complementary and alternative medicine for autism spectrum disorders: Rationale, safety and efficacy.

Journal of Paediatrics and Child Health

49(9), e. 438-442.

Read Abstract (New Window)